
Propanc Biopharma, Inc. - Common Stock
Share · US74346N4043 · PPCB (XNAS)
No Price
26.08.2025 20:32
Current Prices from Propanc Biopharma, Inc. - Common Stock
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
PPCB
|
USD
|
26.08.2025 20:32
|
3,04 USD
| -0,32 USD
-9,52 %
|
Company Profile for Propanc Biopharma, Inc. - Common Stock Share
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
Company Data
Name Propanc Biopharma, Inc. - Common Stock
Company Propanc Biopharma, Inc.
Symbol PPCB
Website
https://www.propanc.com
Primary Exchange
NASDAQ

ISIN US74346N4043
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO James Nathanielsz
Market Capitalization 124 Mio
Country Australia
Currency USD
Employees 0,0 T
Address 302, 6 Butler Street, 3124 Camberwell
IPO Date 2012-11-12
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | PPCB |
More Shares
Investors who hold Propanc Biopharma, Inc. - Common Stock also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.